2000
DOI: 10.1046/j.1440-1681.2000.03377.x
|View full text |Cite
|
Sign up to set email alerts
|

Responses Of Regional Kidney Perfusion To Vasoconstrictors In Anaesthetized Rabbits: Dependence On Agent And Renal Artery Pressure

Abstract: 1. We tested the effects of intravenous infusions of angiotensin II (AngII; 300 ng/kg per min) and the vasopressin V1 receptor agonist [Phe2,Ile3,Orn8]-vasopressin (30 ng/kg per min) on regional kidney perfusion in an extracorporeal circuit model in anaesthetized rabbits in which renal artery pressure (RAP) can be set independently of systemic mean arterial pressure. To test whether the level of RAP can influence the renal vascular response to [Phe2,Ile3,Orn8]-vasopressin, we compared its effects when RAP was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
8
0

Year Published

2002
2002
2012
2012

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 29 publications
3
8
0
Order By: Relevance
“…The results of our present study confirm previous observations by ourselves 2–4,17 and others 5,6,10,12,14,18–20 showing that vasoactive stimuli have diverse effects on regional kidney blood flow. Our major novel finding was that indomethacin abolished increases in MBF following bolus renal arterial administration of ET‐1 and AngII.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…The results of our present study confirm previous observations by ourselves 2–4,17 and others 5,6,10,12,14,18–20 showing that vasoactive stimuli have diverse effects on regional kidney blood flow. Our major novel finding was that indomethacin abolished increases in MBF following bolus renal arterial administration of ET‐1 and AngII.…”
Section: Discussionsupporting
confidence: 93%
“…Increases in MBF in response to AngII and ET‐1 have been observed previously by ourselves 2,23,27,28 and others 10,11,14,20 under a variety of experimental conditions. Our present results indicate that release of vasodilator COX products mediates vasodilatation of the vascular elements that control MBF in response to ET‐1 and AngII, because both AngII‐ and ET‐1‐induced increases in MBF were abolished by indomethacin.…”
Section: Discussionsupporting
confidence: 76%
“…Nevertheless, this seems to be a less serious problem for MBF (than for CBF), because the slope of the MLDF-RBF relationship in the isolated kidney was only slightly Ͻ1. We can also be confident that we can detect increases in MBF with the techniques used here, because we previously detected increases in CLDF and MLDF in response to vasodilators such as acetylcholine and bradykinin (30,33) and increases in MLDF in response to angiotensin II and endothelin-1 in a standard anesthetized rabbit preparation and in the extracorporeal circuit preparation (10)(11)(12). For example, in our standard rabbit preparation, a bolus of bradykinin into the renal artery has been shown to increase MLDF by ϳ100% from a baseline of ϳ100 units.…”
Section: Strengths and Limitations Of Laser-doppler Flowmetry For Estmentioning
confidence: 68%
“…The extracorporeal circuit has been described in detail (5,7,11,43). Briefly, blood was withdrawn at 90 ml/min from the aorta with a roller pump (Masterflex model 7521-45, Barnant, Barrington, IL) and returned to the rabbit via the vena cava and renal artery.…”
Section: Extracorporeal Circuitmentioning
confidence: 99%
“…Secondly, given that vasoactive hormones can differentially affect blood flow in the renal cortex and medulla (Evans et al 2000b), it seems reasonable to hypothesize that they might also differentially affect responses to activation of the renal nerves in these vascular territories, yet this hypothesis has not previously been tested. Therefore, in the present study we determined the effects of renal arterial infusions of a range of vasodilator (the NO donor methylamine hexamethylene NONOate (MAHMA NONOate), acetylcholine and adrenomedullin) and vasoconstrictor agents (angiotensin II and the vasopressin V ]-vasopressin can reduce medullary but not cortical perfusion (Evans et al , 2000a. In pilot studies, we were unable to demonstrate selective effects of vasodilators within specific renal vascular territories, so agents were chosen that might potentially act through different signalling cascades.…”
mentioning
confidence: 99%